Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer-Reference-Cited by-同舟云学术

Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer

Published:2017-03-16 Issue:21 Volume:8 Page:34796-34810
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lindquist Kajsa Ericson¹,Karlsson Anna²,Levéen Per¹,Brunnström Hans¹³,Reuterswärd Christel²,Holm Karolina²,Jönsson Mats²,Annersten Karin²,Rosengren Frida²,Jirström Karin¹³,Kosieradzki Jaroslaw⁴,Ek Lars⁴,Borg Åke²⁵,Planck Maria²⁶,Jönsson Göran²⁵,Staaf Johan²⁵

Affiliation:

1. Department of Pathology, Regional Laboratories Region Skåne, Lund SE 22185, Sweden

2. Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund SE 22381, Sweden

3. Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE 22185, Sweden

4. Department of Respiratory Medicine and Allergology, Skane University Hospital, Lund SE22185, Sweden

5. CREATE Health Strategic Center for Translational Cancer Research, Lund University, Medicon Village, Lund SE 22381, Sweden

6. Department of Oncology, Skåne University Hospital, Lund SE 22381, Sweden

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on lung cancer stem cells in epidermal growth factor receptor–tyrosine kinase inhibitor targeted therapy resistance in lung adenocarcinoma;Oncology and Translational Medicine;2024-02

2. Diagnostic impact of RNA-based next-generation sequencing fusion panel for solid tumors: A single-institution experience;American Journal of Clinical Pathology;2023-11-24

3. Gene Expressions and High Lymphocyte Count May Predict Durable Clinical Benefits in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors;Cancers;2023-09-08

4. Brief Report: Prognostic Relevance of 3q Amplification in Squamous Cell Carcinoma of the Lung;JTO Clinical and Research Reports;2023-04

5. Brief Report: Prognostic relevance of 3q amplification in squamous cell carcinoma of the lung;2022-09-30